Stifel analyst Daniel Arias raised the firm’s price target on Illumina to $265 from $235 and keeps a Buy rating on the shares. Q1 revenue and EPS beat, though the FY23 guidance went unchanged, notes the analyst, who calls management’s commitment to out-year margin improvement "a nice surprise." The firm believes that the Grail deal will go through, though "not as quickly as many would like, which can allow for upside that is "obviously compelling," but "only for those with the tolerance for some drama along the way."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ILMN:
- Illumina price target raised to $229 from $224 at Baird
- Illumina reports Q1 non-GAAP EPS 8c, consensus 2c
- Illumina Reports Financial Results for First Quarter of Fiscal Year 2023; Announces Commitment to Accelerate Margin Growth
- Illumina sees FY23 non GAAP EPS $1.25-$1.50, consensus $1.41
- Illumina options imply 5.4% move in share price post-earnings